Strategy for genotoxicity testing and stratification of genotoxicity test results - Report on initial activities of the IWGT Expert Group

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 540, Issue 2, 2003, Pages 177-181

  Müller, Lutz ^a   Blakey, David ^b   Dearfield, Kerry L ^c   Galloway, Sheila ^d   Guzzie, Peggy ⁿ   Hayashi, Makoto ^e   Kasper, Peter ^f   Kirkland, David ^g   MacGregor, James T ^h   Parry, James M ⁱ   Schechtman, Leonard ^h   Smith, Andrew ^j   Tanaka, Noriho ^k   Tweats, David ^l   Yamasaki, Hiroshi ^m  

^a NOVARTIS PHARMA AG   (Switzerland)

^b HEALTH CANADA   (Canada)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

^e NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^f Fed Inst for Drugs/Med Devices   (Germany)

^g Department of Genetic and Molecular Toxicology   (United Kingdom)

^h CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

ⁱ SWANSEA UNIVERSITY   (United Kingdom)

^j HEALTH AND SAFETY EXECUTIVE   (United Kingdom)

^k HATANO RESEARCH INSTITUTE   (Japan)

^l GLAXOSMITHKLINE   (United Kingdom)

^m KWANSEI GAKUIN UNIVERSITY   (Japan)

ⁿ NONE

more..

Author keywords

Genotoxicity

Indexed keywords

CARCINOGEN; CLASTOGEN; HYDROQUINONE; MUTAGENIC AGENT; PROCARBAZINE; URETHAN;

CARCINOGENICITY; DOSE RESPONSE; GENETIC TOXICOLOGY; GENOTOXICITY; HAZARD; HUMAN; MICRONUCLEUS TEST; MUTAGEN TESTING; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TOXICITY TESTING;

EID: 0141673214     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2003.07.007     Document Type: Article

References (21)

1. Ashby J. The prospects for a simplified and internationally harmonized approach to the detection of possible human carcinogens and mutagens. Mutagenesis. 1:1986;3-16.
2. U.S. Environmental Protection Agency (USEPA), Guidelines for mutagenicity risk assessment, Federal Register 51 (1986) 34006-34012.
3. Dearfield K.L., Auletta A.E., Cimino M.C., Moore M.M. Considerations in the U.S. Environmental Protection Agency's testing approach for mutagenicity. Mutat. Res. 258:1991;259-283.
4. EU: Anon. Testing of Medicinal Products for their Mutagenic Potential. The Rules Governing Medicinal Products in the European Union, vol. 3B, 1998, pp. 45-50.
5. OECD: Ninth Addendum to the OECD Guidelines for the Testing of Chemicals, OECD, Paris, 1998.
6. ICH S2A: Specific Aspects of Regulatory Genotoxicity Tests for Pharmaceuticals, http://www.ifpma.org/ich1.html .
7. ICH S2B, A Standard Battery for Genotoxicity Testing of Pharmaceuticals, http://www.ifpma.org/ich1.html .
8. OECD: Globally Harmonised System for Hazard Classification and Communication (GHS) ENV/JM/MONO (2001) 6, http://www.unece.org/trans/main/dgdb/dgsubc4/c4inf3.html .
9. EU: Anon. Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances, Off. J. Eur. Comm. 196 (1967) 1-98.
10. EU: Anon. Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market, Off. J. Eur. Comm. L 230 (1991) 1-32.
11. EU: Anon. Directive of the European Parliament and of the Council No 98/8/EC of 16 February 1998 on the placing of biocidal products on the market, Off. J. Eur. Comm. L 123 (1998) 1-63.
12. EU: Anon. Technical Guidance Document (TGD) in support of Commission Directive 93/67/EEC on Risk Assessment for New Notified Substances, Commission Regulation (EC) No. 1488/94 on Risk Assessment for Existing Substances and Directive 98/8/EC concerning the placing of biocidal products on the market (test strategy, Part I, Chapter 2, p. 3.10), update final version June 2002.
13. COM, Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment, Guidance on a strategy for testing of chemicals for mutagenicity, Department of Health, UK, 2000, http://www.doh.gov.uk/com.htm .
14. Mutat. Res. 312 (1994) whole issue.
15. Environ. Mol. Mutagen. 35 (2000) whole issue.
16. D.J. Tweats, Follow-up of in vitro positive results, in: P.F. D'Arcy, D.W.G. Harron (Eds.), Proceedings of the Second International Conference on Harmonisation (ICH), Greystoke Books Ltd., Antrim, Northern Ireland, 1994, pp. 240-244.
17. L. Müller, The significance of positive results in genotoxicity testing, in: P.F. D'Arcy, D.W.G. Harron (Eds.), Proceedings of the Fourth International Conference on Harmonisation, Brussels, 1997, Greystone Books Ltd., Antrim, Northern Ireland, 1998, pp. 253-259.
18. Müller L., Kikuchi Y., Probst G., Schechtman L., Sofuni T., Tweats D. ICH-harmonised guidances on genotoxicity testing of pharmaceuticals: evaluation, reasoning and impact. Mutat. Res. 436:1999;195-225.
19. Galloway S.M. Cytotoxicity and chromosome aberrations in vitro: experience in industry and the case of an upper limit on toxicity in the aberration assay. Environ. Mol. Mutagen. 35:2000;191-201.
20. MacGregor J.T., Casciano D., Müller L. Strategies and testing methods for identifying mutagenic risks. Mutat. Res. 455:2000;3-21.
21. Dearfield K.L., Cimino M.C., McCarroll N.E., Mauer I., Valcovic L.R. Genotoxicity risk assessment: a proposed classification strategy. Mutat. Res. 521:2002;121-135.